Early IntraVenous Administration of Nutritional Support
Key facts
- Who runs it
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Where
- Italy1 site in 1 countryChoose a country to see its locations
- Trial code
- Status
- Terminated
- People taking part
- 34 people enrolled
- Started
- 14 Apr 2020
- Ended
- 30 Jul 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Nutritional counseling alone
- Early supplemental parenteral nutrition plus nutritional counseling
- Record updated
- 7 May 2025
- Why it stopped
- Changes in anticancer treatment protocols which limit recruitment
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- histologically confirmed diagnosis of metastatic gastric and gastroesophageal cancer
- no previous chemotherapy for metastatic disease
- indication for a first-line chemotherapy with a combination of 2 drugs including platinum derivatives (plus Trastuzumab if HER2+) to be used by investigator's choice within the framework of good clinical practice and in agreement with current Italian Association of Medical Oncology guidelines
- measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST)
- presence of nutritional risk (Nutritional Risk Screening 2002 score ≥3)
- availability of permanent venous access (Port, Groshong, PICC)
- Eastern Cooperative Oncology Group (ECOG) performance status ≤2
- availability of a home parenteral nutrition service to continue nutritional plan as scheduled
- signed informed consent
Who cannot take part
- contraindication to parenteral nutrition (abnormal glucose and electrolytes control, hyper-triglyceridemia, impaired hemodynamic control and fluid retention)
- age <18 years
- ECOG performance status >2
- indication to complete artificial nutrition support (totally compromised spontaneous food-intake)
- availability of jejunostomy for nutritional purposes
- ongoing home artificial nutrition
- unfeasible home parenteral nutrition for social/familial reasons
- absence of caregivers
- patients refusal
Where is this trial?
It has locations in one country. Choose a country to see its locations.
What happens in this trial
What the trial wants to find out
The present trial will be conducted to verify if early supplemental parenteral nutrition in combination with nutritional counseling improves survival and the feasibility of chemotherapy, in addition to nutritional status, body composition, functional status and quality of life in treatment-naïve patients with metastatic gastric cancer at nutritional risk undergoing first-line chemotherapy.
The 2 groups in the trial
- Nutritional counseling aloneOther group
Nutritional counseling consists of a personalized dietary prescription with regular consultation by a registered dietitian and telephone interviews, as well as of the use of oral nutritional supplements, when necessary.
- Supplemental parenteral nutrition plus nutritional counselingTreatment being tested
Patients will receive nutritional counseling in combination with systematic early supplemental home parenteral nutrition since diagnosis.
Treatment: Early supplemental parenteral nutrition plus nutritional counseling
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early IntraVenous Administration of Nutritional Support (IVANS) in Metastatic Gastric, Cancer Patients at Nutritional Risk Undergoing First-line Chemotherapy
- Publications
- Record updated
- 7 May 2025